Kemira Announces Construction of Two New Coagulant Plants in Germany and Spain

Kemira will strengthen its European manufacturing network by constructing two new coagulant plants in Germany and Spain. The investment is EUR 40 million and the plants are expected to be operational during 2012.

Kemira has entered a strategic partnership with Bayer MaterialScience through which it will purchase hydrochloric acid (= HCl) - a by-product of Bayer’s polyurethane production - to produce coagulants for use in various water treatment applications, including drinking water and waste water treatment.

Kemira will build the new coagulant plants next to Bayer MaterialScience’s isocyanate production plants in Dormagen, Germany and Tarragona, Spain. At the same time, Kemira will close an existing coagulant plant in Europoort, the Netherlands. In Spain, the coagulant manufacturing in Tarragona will be moved into the new plant in the Bayer Industrial Park. Kemira has informed the Works Councils about the restructuring plan and started the co-determination negotiations in Spain and the Netherlands. The impact on personnel is minor, as most employees will be able to transfer to other positions within Kemira.

"Kemira and Bayer have a long history of working together. We are extremely pleased to enter this partnership, as it strengthens our position in western and southern Europe, securing a long term, cost-efficient access to hydrochloric acid. Coagulants are one of Kemira’s core product lines and ensuring cost efficient supply of raw materials is one of our key strategic objectives", says Harri Kerminen, President and CEO of Kemira.

"Bayer MaterialScience is pleased to be entering the strategic partnership with Kemira" says Tony Van Osselaer, the company’s head of Industrial Operations and a member of its Executive Committee. "This partnership provides an environmental benefit, as we will reduce the current transport of our HCl from roads and rail networks. By positioning these new facilities next to our manufacturing units everyone benefits and it gives us a perfect outlet for HCl of our planned TDI (toluene diisocyanate) facility in Dormagen" he adds.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.